CBD AS TREATMENT OPTION FOR EPILEPSY
This page contains video resources from the provincial webinar, held in collaboration with Epilepsy Calgary Association, on Zoom, on June 17, 2021.
The EEA offers these resources to anyone interested in learning more about this important conversation. The webinar was presented by the following three panelists (click on the panelists’ names to view their bios):
Dr. Richard Huntsman, MD, FRCPC, Associate Professor Pediatric Neurology
Dr. Julia Jacobs-LeVan, MD, M.Sc., Director, Pediatric Epilepsy Program, Alberta Children’s Hospital
Dr. Evan Cole Lewis MD, FRCPC, CSCN EEG Diplomate, Director, Neurology Centre of Toronto
To access the full webinar presentation recording click on the first video icon below.
For specific segment of the session, click on the titles below. All these videos are freely available on the EEA VIMEO Channel.
CBD AS TREATMENT OPTION FOR EPILEPSY – FULL WEBINAR RECORDING 1:01:51 SECONDS
CANNABINOID IN EPILEPSY – HOW DO THEY WORK?
PRESENTATION BY DR. RICHARD J. HUNTSMAN
23:35 SECONDS
This video segment contains the full presentation by Richard J. Huntsman MD, FRCP(C), Division of Pediatric Neurology, Cannabinoid Research Initiative of Saskatchewan (CRIS). The presentation learning objectives include:
- Cannabis 101: the plant and bioactive compounds
- Endocannabinoid system in Epilepsy
- Anti-convulsant effects of the phytocannabinoids
EVIDENCE FROM RESEARCH STUDIES – DOES CBD HOLD UP TO ITS PROMISE?
PRESENTATION BY DR. JULIA JACOBS-LEVAN, MD, M.SC., DIRECTOR PAEDIATRIC EPILEPSY PROGRAM, ALBERTA CHILDREN’S HOSPITAL
20:35 SECONDS
This video segment contains the full presentation by Dr. Julia Jacobs-LeVan, MD, M.Sc., Director, Pediatric Epilepsy Program, Alberta Children’s Hospital.
The presentation addresses the following questions:
- Is CBD as effective/or better than other antiepileptic drugs?
- Are side effects less common than in other antiepileptic drugs?
- What is special about the access to CBD compared to other drugs?
CANNABIS IN CANADA – CURRENT BARRIERS TO ACCESS
PRESENTATION BY DR. EVAN COLE LEWIS MD, FRCPC, CSCN EEG DIPLOMATE, DIRECTOR, NEUROLOGY CENTRE OF TORONTO
19:06 SECONDS
This video segment contains the full presentation by Dr. Evan Cole Lewis MD, FRCPC, CSCN EEG Diplomate, Director, Neurology Centre of Toronto. The presentation’s objectives include:
- History of cannabis regulation
- Framework for authorization of medical cannabis
- Challenges faced translating a regulatory framework to clinical practice: RCT vs RWE